Stromelysin-3: a potent marker for histopathologic differentiation between desmoplastic trichoepithelioma and morphealike basal cell carcinoma

Am J Dermatopathol. 1998 Apr;20(2):140-2. doi: 10.1097/00000372-199804000-00006.

Abstract

Histopathological differentiation between desmoplastic trichoepithelioma (DTE) and morphealike basal cell carcinoma (BCC) is a difficult problem because of their similar morphological features. The matrix metalloproteinase stromelysin-3 (ST-3), which is expressed as a specific fibroblastic factor especially surrounding carcinoma cells, was studied in these both conditions of wholly different clinical outcome. Using formalin-fixed paraffin-embedded tissues, we found positive immunoreactivity for ST-3 in fibroblastic cells surrounding morphealike BCC cells in 34 (68%) of 50 cases, whereas the epithelial tumor cells themselves were negative. In none of the 12 cases of DTE did we observe expression of ST-3 in fibroblasts. We conclude that the antibody against ST-3 protein is an immunohistochemical marker to distinguish morphealike BCC from DTE.

MeSH terms

  • Biomarkers, Tumor / analysis
  • Carcinoma, Basal Cell / chemistry*
  • Carcinoma, Basal Cell / pathology
  • Diagnosis, Differential
  • Humans
  • Immunohistochemistry
  • Matrix Metalloproteinase 11
  • Metalloendopeptidases / analysis*
  • Neoplasms, Basal Cell / chemistry*
  • Neoplasms, Basal Cell / pathology
  • Predictive Value of Tests
  • Sensitivity and Specificity

Substances

  • Biomarkers, Tumor
  • Matrix Metalloproteinase 11
  • Metalloendopeptidases